TGFB1 and colon carcinoma: For instance, constitutively repressing endogenous TGFβ1 expression and aTGFβ activity in human colon carcinoma cells retained their functional receptor complexes and the ability to respond to exogenous TGFβ but led to a more progressed phenotype [19].